Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Z1046: a new specific peripheral dopaminergic compound

P Ferlenga1, D Zanzottera, I Biasini

  • 1Zambon Group, Bresso, Milan, Italy.

Acta Physiologica Hungarica
|January 1, 1996
PubMed
Summary

Z1046 is a potent and specific dopamine receptor agonist, distinct from other dopaminergic agents like dopamine, dopexamine, and fenoldopam. Its selective action offers a unique pharmacological profile for potential therapeutic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Absence of interaction between rivaroxaban, tacrolimus and everolimus in renal transplant recipients with deep vein thrombosis or atrial fibrillation.

Vascular pharmacology·2020
Same author

[Health Technology Assessment of meningococcal B vaccine (Trumenba<sup>®</sup>) in adolescent in Italy].

Journal of preventive medicine and hygiene·2020
Same author

Burden of typhoid fever and cholera: similarities and differences. Prevention strategies for European travelers to endemic/epidemic areas.

Journal of preventive medicine and hygiene·2020
Same author

Coronary Microvascular Dysfunction Predicts Long-Term Outcome in Simultaneous Pancreas-Kidney Transplantation.

Transplantation proceedings·2016
Same author

Topic: Rare and Special Cases, The Real "Strange Cases".

Hernia : the journal of hernias and abdominal wall surgery·2015
Same author

Surface Study of Lithium-Air Battery Oxygen Cathodes in Different Solvent-Electrolyte pairs.

Langmuir : the ACS journal of surfaces and colloids·2015

Area of Science:

  • Pharmacology
  • Neuroscience

Background:

  • Peripheral dopamine receptor activation causes vasodilation and neurohormonal changes.
  • Dopamine affects multiple adrenergic receptors.
  • Dopexamine exhibits beta 2 agonist activity and inhibits neuronal uptake.
  • Fenoldopam selectively stimulates D1-like receptors, increasing renin release.

Purpose of the Study:

  • To characterize the pharmacological profile of Z1046.
  • To compare Z1046's selectivity with other dopaminergic agents.

Main Methods:

  • Assessing Z1046's activity at dopamine receptors.
  • Evaluating Z1046's selectivity against adrenergic and serotoninergic (5-HT2) receptors.

Main Results:

Related Experiment Videos

  • Z1046 demonstrated potent mixed dopaminergic agonist activity.
  • Z1046 showed high selectivity over adrenergic and 5-HT2 receptors.

    • Conclusions:

    • Z1046 possesses a unique pharmacological profile as a potent and specific dopamine receptor agonist.
    • This distinct profile differentiates Z1046 from dopamine, dopexamine, and fenoldopam.